InfuSystems (INFU) vs Pro-Dex (PDEX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Pro-Dex (PDEX) has outperformed InfuSystems (INFU) over the past year, gaining 91.3% versus a gain of 31.1%. Over five years, PDEX leads with a +144.3% price change compared with +3.6% for INFU. InfuSystems is the larger company by market cap ($265.5 million vs $201.2 million), about 1.3 times the size.
On valuation, Pro-Dex trades at a lower forward P/E (18.7x vs 25.6x for InfuSystems).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INFU | PDEX |
|---|---|---|
| Share price | $13.33 | $62.80 |
| Market cap | $265.50M | $201.17M |
| 1-day change | +0.45% | -3.27% |
| YTD return | +48.61% | +63.20% |
| 1-year return | +31.07% | +91.35% |
| 5-year return | +3.57% | +144.26% |
| P/E ratio (TTM) | 33.33 | 15.24 |
| Forward P/E | 25.63 | 18.69 |
| EPS (TTM) | $0.40 | $4.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.85 | $77.00 |
| 52-week low | $7.29 | $23.47 |
| Distance from 52-week high | -3.75% | -18.44% |
| Average volume | 141.49K | 81.50K |
| Shares outstanding | 19.92M | 3.20M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PDEX has outperformed INFU by 60.3 percentage points over the past year.
- InfuSystems trades at a higher earnings multiple (33.3x vs 15.2x trailing P/E).
INFU vs PDEX FAQ
Which is bigger, InfuSystems or Pro-Dex?
InfuSystems (INFU) is larger, with a market capitalization of $265.50M compared with $201.17M for Pro-Dex (PDEX).
Which stock has performed better over the past year, INFU or PDEX?
PDEX returned +91.35% over the past 12 months, compared with +31.07% for INFU (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, INFU or PDEX?
PDEX has the lower trailing P/E at 15.2, versus 33.3 for INFU. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are InfuSystems and Pro-Dex in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.